chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was sitting after the vaccine. About 15 minutes later, she stated she felt light headed and dizzy and started feeling clammy and sweating. She was also pale in color. She stated she did not feel well. We gave her Gatorade while we checked her blood pressure. It was 85/60 with a pulse of 57. after a couple minutes and some sips of Gatorade she said she was feeling a little better. She sat for another 10 minutes and went to the restroom. After she came back to the restroom, we took her blood pressure again and it was 93/68 with a pulse of 60. She stated she felt much better and decided she would go home with her companion. We called her at 7:30 pm to check in on her and she stated she felt much better, only pain in the arm, as expected.
After receiving all 4 doses of the COVID-19 vaccine I had a breakthrough of COVID. I had tightness in my chest, a lingering cough, trouble breathing. I was treated with Phenazone and Arborol haler. I acupuncture treatments.
Headache SORE ARM AT INJECTION SITE RESOLVED IN 3 DAYS. HEADACHE RESOLVED IN ONE HOUR. Narrative:
I had the symptoms that they mention dizziness that same night I took it and tired.  The next day (31st) back pain.  Then the following days nothing.  But then by Tuesday (4/6) of the next week I started feeling pain in my right arm and then sometimes I would get the sensation of it falling asleep.  I havent felt that sensation anymore since Sunday (4/11).  By Friday (4/9) I started feeling pressure in my chest in the mornings.  I have been having these two discomforts till today.  Yesterday was the worst feeling it was morning and then all of a sudden everything went white and I was about to faint then my heart started racing so fast.  I have never experienced any of these symptoms in my life.  I am not a person that gets sick or is sick of something.
annoying; she has lost some inches, she was five six but now is five foot three inches.; headaches; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A 85 year-old female patient received bnt162b2 (BNT162B2), administration date 28May2021 (Lot number: EWON1) at the age of 85 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "heart" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "thyroid" (unspecified if ongoing); "blood sugar" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL taken for heart alternation, start date: 2015; METFORMIN taken for blood glucose abnormal; HYDROCHLOROTHIAZID taken for hypertension; LEVOTHYROXINE SODIUM taken for thyroid disorder; BABY ASPIRIN. The following information was reported: HEADACHE (non-serious) with onset 30May2021, outcome "unknown", described as "headaches"; IRRITABILITY (non-serious), outcome "unknown", described as "annoying"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "she has lost some inches, she was five six but now is five foot three inches.".  Additional information: She reports that since 30May2021 she has been experiencing headaches everyday, stating, "they're not very bad, but enough to be annoying" and "I don't usually have headaches, and I think that's what bothered me the most".She does report other medical issues and that she take different medications, but the Covid vaccine was the only change.She has not gotten the second dose of the Pfizer covid vaccine, but does take covid tests, weekly.She heard from her family members, "they said the second one is always worse than the first" and she stated "not everything is for everybody". She had got her first shot on 28May2021. She has a lot of medical problems that she takes medication for. That could be causing her to have headaches with the shot or something is going wrong. She didn't have any headaches the first two days after the shot. Then on 30May2021, she started having headaches. They are not really bad headaches, but enough to be annoying. She didn't normally have headaches. She has headache daily since having the shot. She is wondering if that was a side effect.  No follow-up attempts are possible. No further information is expected.
Pt. states that after receiving the 3rd dose of Moderna 01/04/2022, started experiencing symptoms 01/05/2022 of Optical Migraine with tunnel vision, loss of color, and vertigo. Primary visit 01/06/2022/Ophthalmologist with recommendations of MRI (Normal). Symptoms have subsided.
At the time of injection, the site became swollen and tender, and was red, itchy, and warm to the touch. I knew this was a normal side effect so I was not worried.  They faded after a couple of days. However, a week after the injection, these side effects returned. My arm was not as tender but it is itchy, red, warm, and swollen (feels firm.) I doubt it is anything serious but I figured I should report it just in case.
Approximately 6-7 hours after receiving the flu shot, patient developed flu-like symptoms: chills, arthralgia, low grade fever, headache, lethargy.  Patient has received annual flu shot every year for 20+ years and not experienced any adverse events.  Adverse events persist  and are ongoing as of  the time of this report (approximately 24 hours from receiving shot).
was able to taste flavors she had not experienced in the previous 4 years, also reported a 'flowery' smell that seems to be related to external stimuli (which was not previously the case); This is a spontaneous report from a contactable consumer. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 16Apr2021 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included traumatic brain injury (TBI) approximately four years ago and the patient had lost sense of smell and taste. Prior to the vaccination, it was unknown if the patient was diagnosed with COVID-19 and also unknown that if the patient had allergies to medications, food, or other products. Concomitant medications were not reported and it was unknown if the patient received any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 21Apr2021, the patient was able to taste flavors she had not experienced in the previous four years. The patient also reported a 'flowery' smell that seemed to be related to external stimuli (which was not previously the case). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events able to taste flavors she had not experienced in the previous four years and 'flowery' smell that seemed to be related to external stimuli was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
INJECTION SITE PAIN; LUMP AT SITE OF INJECTION; This spontaneous report received from a patient concerned a 37 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) .5 ml, administered on 04-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 04-MAR-2021, the subject experienced lump at site of injection. On 05-MAR-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site pain, and lump at site of injection. This report was non-serious.
PATIENT DEVELOPED HYPOXIA, PNEUMONIA, PLEURAL EFFUSION AND LEFT LUNG PULMONARY EMBOLI  PATIENT WAS TREATED WITH ANTIBIOTICS, OXYGEN ANDF STARTED ON HEPARIN DRIP, WHICH WAS D/C AND PATIENT WAS STARTED ON LOVENOX PRIOR TO D/C. PATIENT ALSO NOTED TO HAVE PULMONARY NODULES ON IMAGING AND ARRANGMENTS MADE TO F/U OUTPATIENT FOR BIOPSY.
Vertigo type symptoms - spinning, off balance, dizziness, eye disturbances, headache  Went away after about 12-14 days however has now come back in May 2023 and September 2023 so far
Felt sick for several weeks after shot.  Then in January started fainting when got strep.  And by March started having full on seizures.  Was in perfect health prior to the flu shot.
This spontaneous report has been received from a pharmacist referring to a 66 years old patient of unknown gender. Information about medical history, concurrent conditions, concomitant medications and drug reactions was not provided. On 23-JUL-2018 the patient inadvertently received an expired dose of PNEUMOVAX 23)(1 dosage form (DF); lot # M043424; expiration date 06-JUN-2018; route and site of administration were not reported). No adverse effects were reported. No product quality complaint (PQC) was involved.
Presented with cough, shortness of breath; + covid 2 days prior; admitted with Covid PNA to medical; tx with maxipime, singulair, zinc CT chest ruled out PE. Pt is eager to go home  Pt is being discharged home in a stable state after arranging home o2
Red welt at injection site. Warm to touch and tender. Spread from 1/2 X 1 1/2 inch to wider and more diffuse from first day. Still there 4 days later...today January 29th.
One week later after injection on 1/11/21  I experience swollen and painful lymph nodes near upper breast near axillary area. Also my injection site which was swollen and raised, hot to touch.  I went to employee health who administered the vaccine and they prescribed me Keflex. Which I am still taking
This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (left arm red), PAIN IN EXTREMITY (left arm sore), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination. No medical history was provided. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication. On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced ERYTHEMA (left arm red), PAIN IN EXTREMITY (left arm sore), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills). On 09-Mar-2021, ERYTHEMA (left arm red), PAIN IN EXTREMITY (left arm sore), HEADACHE (headache), PYREXIA (light fever) and CHILLS (chills) had resolved. Treatment information was not provided. This case was linked to MOD-2021-292499.
Rash- generalized raised macular rash, blotchy in some areas, dense in many areas. scratching, head to toe. Prescribed hydroxyzine
Pt recvd Hep B vax & 48 hrs p/vax pt exp fatigue; No further details were provided;
Pain in throat which I thought was reflux for over a month. Pain became extreme and painful to touch neck. Went ent and endocrinologist who said I had thyroiditis and said it was from a virus. I have not had a virus and was tested weekly before getting vaccine. Only thing I had was the vaccine
Post vax, this pt developed fever and had aches and was in bed for 2-3 days. Follow-up information received indicated that the pt developed cellulitis and a swollen and red arm around the injection site and down to below the elbow.
Flu-like symptoms, except no fever. Headache, muscle ache, chills, shivering.
small discoloration at vaccine site. I have sent a picture to my doctor.  Doesn't hurt or itch. No discharge.
This spontaneous report as received from a physician via a company representative referring to a male patient of unknown age who on an unknown date was vaccinated with dose 1 of GARDASIL, IM (dose and lot # not provided). No other co-suspects were reported. No concomitant medications were reported. The physician stated that on 04-OCT-2012 "Boy" experienced ticks and he was blinking a lot. No treatment information was reported. Therapy with GARDASIL was discontinued. The outcome of ticks and blinking a lot was unknown. The physician also stated that "don't believe so" that the patient had sought medical attention. The relatedness for ticks and blinking a lot is unknown for GARDASIL. Additional information has been requested.
IPOL, 0.1cc was given intradermally (rather than IM or SQ) in a patient's Lt FA.  Tubersol 0.1cc was supposed to be administered.  Patient was notified of incorrect solution and incorrect route of administration.  Instructed patient to report any rashes, irritation of skin, or other side effects noticed, at the site of the IPOL intradermal site.  Sanofi-Pastuer notified and called for guidance regarding possible side effects of administering IPOL intradermally.  They were not aware of any side effects given the small dose (0.1cc) and route.
Pt recvd Td vax & exp swelling, redness, aching, pruritus @ the site of inject; also exp enlargement of axillary lymph nodes & fever of 2 days duration; sx were treated w/Ibuprofen;
Patient reported being light headed, short of breath/ hard time breathing, nauseous, and hot about 15 minutes after the shot. Administered 10ml of Benadryl to assist with breathing.
pt recv vax 6MAY97 & 12NOV97 pt devel clinical varicella;pt had 12-15 lesions primarily on trunk & a few on upper extremities;a visit to MD was required;
Proquad given to 17 year old for needed vaccination of Measles, Mumps, Rubella and Varicella.  Patient presented with no previous immunizations and was starting all vaccinations from the start.  Proquad was given by mistake, age requirement  for proquad was missed.  No adverse reaction, so no treatment was needed, patient did not show any signs or symptoms of distress or any kind of reaction.  Patient left clinic without issue or concern.
Palms of hands red and itchy appt. an hour after vaccine. Extreme pain on side/torso area developed through the night while sleeping. Developed a head ache and the torso pain continued. Developed rash on day 2. Went to clinic and was diagnosed with Shingles. Was prescribed an antiviral medication. Valtrex.
This spontaneous report as received from a medical assistant refers to a 15 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 02-JUL-2014 the patient was vaccinated with second dose of GARDASIL (dose, frequency and route of administration were not reported) (lot # K005083, expiry date: 04-NOV-2016) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for GARDASIL. This case is linked to 1407USA010956, 1407USA012902, 1407USA012903, 1407USA012904, 1407USA012905, 1407USA012906, 1407USA012907, 1407USA012908, 1407USA012909, 1407USA012911, 1407USA012912, 1407USA012913, 1407USA012914, 1407USA012915, 1407USA012916, 1407USA012917, 1407USA012918, 1407USA012919, 1407USA012920, 1407USA012921, 1407USA012922, 1407USA012923, 1407USA012924, 1407USA012925, 1407USA012926, 1407USA012927, 1407USA012928, 1407USA012929, 1407USA012930, 1407USA012931, 1407USA012932, 1407USA012933, 1407USA012934, 1407USA012935, 1407USA012936, 1407USA012937, 1407USA012938, 1407USA012939, 1407USA012940, 1407USA012941, 1407USA012942, 1407USA012943, 1407USA012944, 1407USA012945, 1407USA012946, 1407USA012947, 1407USA012948, 1407USA012949, 1407USA012950, 1407USA012951, 1407USA012952, 1407USA012953, 1407USA012954, 1407USA012955, 1407USA012956, 1407USA012957, 1407USA012958, 1407USA012959, 1407USA012960, 1407USA012961, 1407USA012962, 1407USA012963, 1407USA012964, 1407USA012965, 1407USA012966, 1407USA012967, 1407USA012968, 1407USA012969, 1407USA012970, 1407USA012971, 1407USA012972, 1407USA012973, 1407USA012974, 1407USA012975, 1407USA012976, 1407USA012977, 1407USA012978, 1407USA012979, 1407USA012980, 1407USA012981, 1407USA012982, 1407USA012983, 1407USA012984, 1407USA012985, 1407USA012986, 1407USA012987, 1407USA012988, 1407USA012989, 1407USA012990, 1407USA012991, 1407USA012992, 1407USA012993, 1407USA012994, 1407USA012995, 1407USA012996, 1407USA012997, 1407USA012998, 1407USA012999, 1407USA013000, 1407USA013013 and 1407USA013014 (same reporter link). Additional information has been requested.
Narrative: mild ADR with bilateral shoulder, right thumb, cervical and right knee intermittent and self-limiting pain one week after first dose of Moderna vaccination.
Patient was given a flu shot and had immediate reaction in which she was red and splotchy and complained of shortness of breath and just an overall odd feeling. she was given 25 mg of diphenhydramine which she had difficulty taking and continued to have problems with breathing and speaking clearly.  Gave a dose of epinephrine while phoning 911. By the time EMS arrived, pts initial symptoms were almost resolved but now with racing heart beat. Was monitored by ems and then taken to the hospital for observation
pt recv vax 3MAY96 & 10MAY96 pt exp backache, fever & malaise;13MAY96 MD devel a gen varicella-like rash w/lesions all over body;28MAY96 sx resolved;
Client requested to lay on stretcher for vaccine, provided. Almost immediately following vaccine, client closed eyes- briefly did not respond to name. Skin warm and dry, strong steady pulse. Responded to verbal stimuli, complained of throat tightening and wheezing. EMT called to client pod. vss. HR76, BP 109/74, sat 97 on room air. Client then closed eyes again, briefly did not respond - then opened eyes . vs's continued stable. As per EMT positive slight wheeze. Ambulance arrived and client transported to ER.
big diameter of redness in injection site / went to ER and was at the hospital for 2 days; sore injection site left arm / went to ER and was at the hospital for 2 days; Fever / went to ER and was at the hospital for 2 days; Headache / went to ER and was at the hospital for 2 days; Shingrix second dose more than  6 month apart from first dose because there were no stock at that time; This case was reported by a physician via call center representative and described the occurrence of injection site erythema in a female patient who received Herpes zoster (Shingrix) (batch number TE493, expiry date unknown) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site erythema (received 1st dose on an unknown date, refer case US2021AMR063811). Concurrent medical conditions included guillain barre syndrome.   On 22nd July 2019, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced injection site erythema (serious criteria hospitalization), injection site pain (serious criteria hospitalization), fever (serious criteria hospitalization), headache (serious criteria hospitalization) and product supply issue. On an unknown date, the outcome of the injection site erythema, injection site pain, fever, headache and product supply issue were unknown.   It was unknown if the reporter considered the injection site erythema, injection site pain, fever and headache to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix late due vaccine was not available at that moment. After receiving 2nd dose of Shingrix in left arm, the patient experienced fever, headache, big diameter of redness in injection site and sore injection site. The patient went to emergency room (ER) and was at the hospital for 2 days. On Thursday 18th March 2021, the patient would receive Covid vaccine at physician's office, but they are afraid of this shot due they do not know the causality of Shingrix side effects. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR063811:same patient
Pt broke out with 9 blisters on 5-3-09 Mom states looks like chickenpox. Blisters on back and neck.
Tired; Muscle aches; Headaches; Felt bad; This case was reported by a physician via sales rep and described the occurrence of tiredness in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tiredness, muscle pain, headache and feeling bad. On an unknown date, the outcome of the tiredness, muscle pain, headache and feeling bad were recovered/resolved.   The reporter considered the tiredness, muscle pain, headache and feeling bad to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient was a health care professional and had received Shingrix dose. The patient felt tired, had muscle aches and had headaches (these were consistent with the label). The patient felt bad for 2 days and then he went for sailing. The reporter stated, patient's wife also received Shingrix and experienced adverse events, refer case US2019AMR167044.
shingrix was administered/after being out of range for 5 days; This case was reported by a other health professional via other manufacturer and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that, the Shingrix vaccine was administered to an unspecified patient after being out of range for 5 days, which led to incorrect storage of drug. The reporter did not specify when Shingrix was administered. On 14th June 2021, the improperly stored Pneumovax 23 was administered to a patient. The reporter did call the other company manufacturer to make aware of the event. No additional adverse events was reported. N further information was provided. No product quality complaint.
No adverse events---Patient was administered a 3rd dose of vaccine when booster was not approved for his age yet.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX, subcutaneously, lot # N008828, expiration date 16-MAR-2019 (dose was not reported) for prophylaxis; administered along with a properly stored sterile diluent, subcutaneously, lot # L028663, expiration date 29-MAR-2018 (dose was not reported) for prophylaxis. It was reported that the vaccine was exposed to temperature of -9 degrees Celsius to 8 degrees Celsius, for a time frame of 4 hours and 4 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. No adverse effects were reported. There was no product quality complaint (PQC) involved. This is one of several reports received form the same reporter (MARRS # 1712USA008050, 1712USA008779, 1712USA008781, 1712USA008782, 1712USA008783, 1712USA008784, 1712USA008785, 1712USA008786, 1712USA008787). Sender's Comments: US-009507513-1712USA008050.
Rash at injection site- about 2 inches in diameter.  Looks and feels like sunburn.  Does not itch.